Welcome to the Cannabis Countdown, the Legal Marijuana Industry’s Number One Curated Weekly News Recap. In This Week’s Edition, We Recap and Countdown the Top 10 Cannabis and Psychedelic Stock News Stories for the Week of March 29th – April 4th, 2021. Without additional ado, let’s get began. * Yahoo Finance readers, please click on right here to view the complete article. 10. TCI Earnings Recap: The 4 Bosses of #MSOGang Report Another Quarter of Triple-Digit Growth In Today’s Earnings Recap We’ll Be Reviewing the Most Recent Quarterly Financial Results and Corresponding Earnings Conference Calls of the Big Four U.S. MSOs, Also Known because the “4 Bosses of #MSOGang” Without additional delay, let’s take a better take a look at the fourth quarter and full-year 2020 earnings from Curaleaf (OTCQX: CURLF), Trulieve (OTCQX: TCNNF), Green Thumb (OTCQX: GTBIF) and Cresco Labs (OTCQX: CRLBF). READ FULL MSOGANG EARNINGS ARTICLE 9. Why Would Anyone Invest in The Psychedelics Medicine Market? The “Right” Thing to Say Would Be That By Investing in Psychedelics, We’re Investing within the Next Evolution of Mental Health Medicines and Therapies Despite a current downturn within the broader markets, in addition to a sell-off within the Psychedelics house – those that acquired in early on the big-name Psychedelic Stocks reminiscent of MindMed (OTCQB: MMEDF), Compass Pathways (NASDAQ: CMPS) and Field Trip Health (OTC: FTRPF) are nonetheless money-good. Of course, these numbers don’t imply a lot proper now. After all, these firms haven’t even scratched the floor when it comes to what they’re going to accomplish over the following three to 5 years. In different phrases, the massive cash has not but been made on these shares. READ FULL PSYCHEDELICS INVESTING 8. RWB Updates Investors on Acquisitions in Michigan, Illinois and Florida, Celebrates Success of PV and High Times Brands Demand for RWB’s Platinum Vape Branded Products Continues to Soar, With PV Reporting Record Michigan Sales of Roughly USD $6.5 Million for the Month of February Red White & Bloom (OTCQX: RWBYF) launched a complete Q1 2021 company replace on Wednesday, bringing traders on top of things on the standing of the corporate’s acquisitions in Michigan, Illinois and Florida. The replace additionally celebrated the large success of RWB’s Platinum Vape and High Times hashish manufacturers. READ FULL RWB ARTICLE 7. 3 Best Marijuana Stocks to Buy in 2021 Here Are Three of the Best U.S. Multi-State Cannabis Operators Tackling a $20 Billion Market Opportunity At an annual progress price of 20% per 12 months, the Marijuana trade has develop into one of many nation’s fastest-emerging industries. Meanwhile, Cannabis Stocks have been giving again some mouthwatering positive factors to traders. In truth, shares of Green Thumb (OTCQX: GTBIF), Trulieve (OTCQX: TCNNF), and Jushi Holdings (OTCQB: JUSHF) have returned 413%, 385%, and 636%, respectively. (Each of those firms operates solely within the States, however has to checklist on the Canadian inventory exchanges to lift capital, as marijuana remains to be unlawful on the federal stage within the U.S.) Let’s take a look at what they’ve in retailer for the longer term. READ FULL MARIJUANA STOCKS ARTICLE 6. COMPASS Pathways Appoints Wayne J Riley MD to its Board of Directors Dr. Riley is President of the State University of New York (SUNY) Downstate Health Sciences University, Brooklyn, Where He Holds Tenured Professorships in Internal Medicine, and Health Policy and Management Compass Pathways (NASDAQ: CMPS), a psychological well being care firm devoted to accelerating affected person entry to evidence-based innovation in psychological well being, introduced in the present day that it has appointed Wayne J Riley MD to its Board of Directors. A major care doctor and an educational, he has greater than 25 years of expertise encompassing medical and tutorial drugs, analysis programme oversight, biotechnology, major care, public well being, healthcare administration and coverage, healthcare high quality, tutorial well being science centre administration, and authorities service. READ FULL CMPS ARTICLE 5. Aphria Reports Independent Proxy Firms Approve of Tilray Merger The Two Firms, Institutional Shareholder Services, and Glass Lewis and CO Have Reportedly Recommended That Shareholders Vote in Favour of the Transaction Aphria (NYSE: APHA) is evidently trying to drum up shareholder help for its proposed transaction with Tilray (NASDAQ: TLRY) (FRA: 2HQ). The agency this morning launched that two separate proxy advisory corporations have offered beneficial voting suggestions to institutional traders for the transaction. READ FULL APHA TLRY ARTICLE 4. MindMed Announces the Publication of New Data on Personalized MDMA Dosing The Study Used Data From 194 MDMA Administrations in Ten Randomized Placebo-Controlled Studies in Healthy Subjects MindMed (OTCQB: MMEDF) introduced the publication of the primary research on MDMA dosing optimization utilizing personalised drugs. The research occurred on the University Hospital Basel Liechti Lab, in Basel, Switzerland. This research supplies the primary scientific information for predicting responses to MDMA and optimizing dosing. This could maximize the potential useful therapeutic results whereas lowering hostile responses when treating medical circumstances. READ FULL MINDMED ARTICLE 3. The Ultimate Guide to Cannabis Legalization in New York The Key Dates to Know, and Which Pot Stocks Could Benefit the Most New York is the 15th state to legalize leisure Cannabis within the U.S. In the Empire State, leisure Marijuana gross sales may balloon to $7 billion as soon as the market is totally established. Seemingly each hashish firm within the nation desires in. The 10 hashish firms that at present function in New York’s medical market have a first-mover benefit. Seven of those operators — together with Curaleaf (OTCQX: CURLF), Green Thumb (OTCQX: GTBIF), and Cresco Labs (OTCQX: CRLBF) — are publicly traded. READ FULL NEW YORK ARTICLE 2. Core One Labs Completes Acquisition of Ketamine Infusions Centers of Texas Representing the Company’s First Psychedelics Clinic within the U.S. The Company Also Announced its Fast Entry Inclusion within the Horizons Psychedelic ETF Core One Labs (OTC: CLABF), a analysis and expertise firm centered in life sciences and on bringing Psychedelic medicines to market by way of novel supply techniques and psychedelic-assisted psychotherapy, is happy to announce it has accomplished the acquisition of Ketamine Infusions Centers of Texas, a U.S.-based well being and wellness clinic that gives ketamine infusion remedy. The transaction marks the primary well being and wellness operation for the corporate within the United States. Also, the corporate introduced that it has been added on a quick entry foundation to the first-ever Psychedelics ETF – the Horizons Psychedelic Stock Index ETF (NEO: PSYK), efficient March 19, 2021. READ FULL CORE ONE ARTICLE 1. Creso Pharma Appoints Leading Cannabis Executive as Director of U.S. Business Development The Company Welcomes New York State Legalization of Recreational Cannabis Creso Pharma (OTC: COPHF) introduced that it has appointed main Cannabis government Mr. John Griese as Director of U.S. Business Development. This follows the worldwide development in direction of hashish legalization in addition to current laws in New York State legalizing leisure Marijuana. READ FULL CRESO PHARMA ARTICLE Photo by Kym MacKinnon on Unsplash See extra from BenzingaClick on right here for choices trades from BenzingaCannabis Countdown: Top 10 Marijuana And Psychedelics Industry News Stories Of The WeekCannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week© 2021 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.